150
Views
9
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae in community setting in Casablanca

, , , , , & show all
Pages 27-32 | Received 05 Jul 2014, Accepted 25 Aug 2014, Published online: 20 Oct 2014

References

  • Eurosurveillance editorial. ECDC publishes the annual epidemiological report 2012. Euro Surveill 2013;18:20418.
  • Pitout JD. Enterobacteriaceae that produce extended-spectrum beta-lactamases and AmpC beta-lactamases in the community: the tip of the iceberg? Curr Pharm Des 2013;19:257–63.
  • Pitout JD, Laupland KB. Extended-spectrum beta- lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 2008;8:159–66.
  • Gniadkowski M. Evolution of extended-spectrum beta- lactamases by mutation. Clin Microbiol Infect 2008; 14(Suppl 1):11–32.
  • Cornaglia G, Garau J, Livermore DM. Living with ESBLs. Introduction. Clin Microbiol Infect 2008;14(Suppl 1):1–2.
  • Herindrainy P, Randrianirina F, Ratovoson R, Ratsima Hariniana E, Buisson Y, Genel N, et al. Rectal carriage of extended-spectrum beta-lactamase-producing gram-negative bacilli in community settings in Madagascar. PLoS One 2011;6:e22738.
  • Soraas A, Sundsfjord A, Sandven I, Brunborg C, Jenum PA. Risk factors for community-acquired urinary tract infections caused by ESBL-producing enterobacteriaceae – a case-control study in a low prevalence country. PLoS One 2013;8(7).
  • Huttner B, Haustein T, Uckay I, Renzi G, Stewardson A, Schaerrer D, et al. Decolonization of intestinal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae with oral colistin and neomycin: a randomized, double-blind, placebo-controlled trial. J Antimicrob Chemother 2013;68:2375–82.
  • Valverde A, Coque TM, Sanchez-Moreno MP, Rollan A, Baquero F, Canton R. Dramatic increase in prevalence of fecal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae during nonoutbreak situations in Spain. J Clin Microbiol 2004;42:4769–75.
  • Tzelepi E, Giakkoupi P, Sofianou D, Loukova V, Kemeroglou A, Tsakris A. Detection of extended-spectrum β-lactamases in clinical isolates of Enterobacter cloacae and Enterobacter aerogenes. J Clin Microbiol 2000;38: 542–6.
  • CLSI. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Second Informational Supplement. Clinical and Laboratory Standards 2012;32:188.
  • Barguigua A, El Otmani F, Talmi M, Reguig A, Jamali L, Zerouali K, et al. Prevalence and genotypic analysis of plasmid-mediated beta-lactamases among urinary Klebsiella pneumoniae isolates in Moroccan community. J Antibiot (Tokyo) 2013;66:11–16.
  • Bourjilat F, Bouchrif B, Dersi N, Claude JD, Amarouch H, Timinouni M. Emergence of extended-spectrum beta- lactamases-producing Escherichia coli in community- acquired urinary infections in Casablanca, Morocco. J Infect Dev Ctries 2011;5:850–5.
  • Barguigua A, El Otmani F, Talmi M, Bourjilat F, Haouzane F, Zerouali K, et al. Characterization of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates from the community in Morocco. J Med Microbiol 2011;60(Pt 9):1344–52.
  • Levin BR. Minimizing potential resistance: a population dynamics view. Clin Infect Dis 2001;33(Suppl 3):S161–9.
  • Canton R, Coque TM, Baquero F. Multi-resistant Gram-negative bacilli: from epidemics to endemics. Curr Opin Infect Dis 2003;16:315–25.
  • Harris AD, Nemoy L, Johnson JA, Martin-Carnahan A, Smith DL, Standiford H, et al. Co-carriage rates of vancomycin-resistant Enterococcus and extended-spectrum beta-lactamase-producing bacteria among a cohort of intensive care unit patients: implications for an active surveillance program. Infect Control Hosp Epidemiol 2004;25:105–8.
  • Bouchrif B, Le Hello S, Pardos M, Karraouan B, Perrier-Gros-Claude JD, Ennaji MM, et al. Ceftazidime- resistant Salmonella enterica, Morocco. Emerg Infect Dis 2009;15:1693–5.
  • Rodriguez-Bano J, Lopez-Cerero L, Navarro MD, Diaz de Alba P, Pascual A. Faecal carriage of extended- spectrum beta-lactamase-producing Escherichia coli: prevalence, risk factors and molecular epidemiology. J Antimicrob Chemother 2008;62:1142–9.
  • Poirel L, Naas T, Nordmann P. Genetic support of extended-spectrum beta-lactamases. Clin Microbiol Infect 2008;14(Suppl 1):75–81.
  • Ruppé E. Épidémiologie des bêta-lactamases à spectre élargi: l'avènement des CTX-M. Antibiotiques 2010;12: 3–16.
  • Jones GL, Warren RE, Skidmore SJ, Davies VA, Gibreel T, Upton M. Prevalence and distribution of plasmid-mediated quinolone resistance genes in clinical isolates of Escherichia coli lacking extended-spectrum beta-lactamases. J Antimicrob Chemother 2008;62: 1245–51.
  • Nordmann P, Poirel L. Emergence of plasmid-mediated resistance to quinolones in Enterobacteriaceae. J Antimicrob Chemother 2005;56:463–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.